Navigation Links
Researchers Develop New Procedure to Screen All 46 Human Chromosomes to Identify Abnormalities in Embryos
Date:10/18/2007

New technology developed by researchers at Reproductive Medicine Associates of New Jersey awarded General Program Prize Paper at American Society for

Reproductive Medicine Annual Meeting

WASHINGTON and MORRISTOWN, N.J., Oct. 18 /PRNewswire/ -- Researchers at Reproductive Medicine Associates of New Jersey (RMA) received the highest award for research at the American Society for Reproductive Medicine (ASRM) for developing a novel technology making it possible to provide accurate, rapid analysis of all 46 human chromosomes from a single cell taken from a human embryo. The ASRM Prize Paper Award is awarded to the most significant research in the field of human reproduction each year. This new technology makes it possible for the first time to fully evaluate the genetic make up of human embryos in a time frame which allows clinicians and scientists to use that information to help improve pregnancy rates, reduce miscarriage risk, and decrease the risk of some major congenital anomalies such as Down syndrome.

This procedure, known as "Accurate 23 chromosome aneuploidy screening in human blastomeres using single nucleotide polymorphisms (SNP)," provides fertility specialists for the first time with a rapid and accurate technique to assess the genetic normality of human embryos created through in vitro fertilization (IVF).

The results of this research effort were presented this week at the American Society for Reproductive Medicine (ASRM) meeting and were awarded the General Program Prize Paper Award, the highest award provided by this international professional society. Nathan Treff, Ph.D., lead author on the study and a researcher in molecular genetics at RMA, delivered the results in an oral presentation. "Accurate and rapid identification of chromosomally- abnormal (aneuploid) embryos within hours after embryo biopsy will provide physicians with the ability to select embryos for transfer to the uterus based on a far more compl
'/>"/>

SOURCE Reproductive Medicine Associates of New Jersey
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Researchers Discover Method for Identifying How Cancer Evades the Immune System
4. Researchers Discover Gene For Rare Skin Disorder
5. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
6. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
7. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
8. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
9. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
10. Researchers Urge Caution in Using ESAs for Cancer-Related Anemia
11. Researchers Identify New Genetic Risk Factors for Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)... BASEL, Switzerland, May 15 /- Patie...orld,s most common cancers, can expect,further tre...Herceptin(R),(trastuzumab) following new data that...f Clinical Oncology (ASCO) annual meeting in Chica...s will attend the meeting which,is the premier eve...
(Date:5/15/2008)...Phase II Data Presented at ASCO Showed Acceptable ...ce of Grade 3 and 4 Neuropathy, WOODCLIFF LAKE, N...emotherapeutic agent eribulin mesylate (E7389) dem...ion of women with locally advanced or metastatic,b...er Phase II clinical,trial. The study also suggest...
(Date:5/15/2008)...ood pressure reductions demonstrated in Blacks, Hi...etes and Obese Individuals, PARSIPPANY, N.J., May...d today that data presented at the American Societ...c Meeting (ASH 2008) in New,Orleans demonstrated t...pine and olmesartan medoxomil) safely and effectiv...
(Date:5/15/2008)... APPENZELL, Switzerland, May 15 /- E...es Food and Drug Administration (FDA) has,granted ...ment of pulmonary,arterial hypertension (PAH). Ter...ivotal Phase II trial in Europe., "The FDA,s gran...encourages and strengthens our development program...
Breaking Medicine Technology:New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Healthcare Crisis Brought to Life in New TV Show 11337 1Flextronics to Acquire the FRIWO Mobile Power Business Unit of CEAG 11334 1Flextronics to Acquire the FRIWO Mobile Power Business Unit of CEAG 11334 2Flextronics to Acquire the FRIWO Mobile Power Business Unit of CEAG 11334 3CorVel to Present at UBS Global Healthcare Services Conference 11332 1CorVel to Present at UBS Global Healthcare Services Conference 11332 2Gene Plays Jekyll and Hyde Role in Deadly Brain Cancer 11331 1
....5 and 40/25 mg/day and Amlodipine +,Benazepril 5/...of,Hypertension Twenty-Second Annual Scientific Me... -- New data,presented today at the American Socie...ic Meeting (ASH 2007) in Chicago,demonstrated that...n medoxomil/hydrochlorothiazide) was associated wi...
...-May 21, 2007 - Medical,professionals seeking to t...cquired gram-negative pneumonia may have a new wea...ct candidate being,developed by Nektar Therapeutic...rial evaluating the use of,NKTR-061 (Inhaled Amika...h hospital-acquired gram-negative pneumonia were,p...
Other Medicine Technology:Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11
(Date:5/16/2008)... - Gefitinib, the once-promising drug formerly app...also known as Iressa, enhanced the effectiveness o...ypes of metastatic breast cancer, according to a P...niversity of Texas M. D. Anderson Cancer Center. ,... first positive study for Iressa in breast cancer,...
(Date:5/16/2008)...ounces appointment of Nomura Code Securities Limit... broker, NEW YORK, May 16 /PRNewswire-FirstCall/ ...estments, Inc. (Amex: MGT ) (the "Company"), and ...Aided Detection (CAD) and,image analysis software ...,of disease, today announced the appointment of NM...
(Date:5/16/2008)...it Portland to Rally Residents to Eat Right, Move ...ts, PORTLAND, Ore., May 16 /PRNewswire/ -- The la...ifferent fad diets -- which seem to go in and out,...ong-term success has been,slim. Two out of three A...ents -- remain overweight or obese., A new campai...
(Date:5/16/2008)...of two proteins in mammalian embryos prevents the ...earchers at the Medical College of Wisconsin, Milw...the May 15 issue of Developmental Biology, was led...gy, neurobiology and anatomy at the Medical Colleg...ly identified the factors responsible for the onse...
Breaking Medicine News(10 mins):Health News:Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy 2Health News:Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy 3Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 3Health News:Message to Oregon Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Oregon Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Medical College of Wisconsin researchers identify proteins that help develop mammalian hearts 2
...ith a common form of brewer's yeast, University of...l functions of a key protein// that allow it to ac...determines gene activity and that, when malfunctio...ous neurological disorders. The work, published in...
... half months after his sexual organ was completely...o lead a normal life again after a Delhi hospital/...e unmarried man from Uttar Pradesh underwent a sev... Sir Ganga Rama Hospital (SGRH), a leading private...
...scientists at Johns Hopkins are making mathematica...ays to perform a surgery.// Surgical tasks such as...illustrated in this model. The team's long-term g...evaluating a surgeon's work and to help doctors im...
...n parliamentarians will attend a two-day conferenc...e's elected representatives in combating the disea...a worldwide network of individual parliamentarians... assembly of Punjab (Pakistan), Pakistan National ...
Other Medicine News:Health News:From a Lowly Yeast, Researchers Divine a Clue to Human Disease 2Health News:Delhi Hospital Reattaches Amputated Penis 2Health News:Robotic Model To Teach Surgical Skills 2Health News:Robotic Model To Teach Surgical Skills 3
... value in high performance electronic pipetting!, ...design reduce hand fatigue and strain , Stress-fre...r coding for easy volume identification , Accepts ...lton AdvanTip Low Retention and AdvanTip Precision...
The Finnpipette BioControl multichannel has the same innovative features as the single channel model.The same universal handle fits all seven multichannel and five single channel tip cone modules. Bo
...s ideal for all liquid handling applications in th...cally-placed operating buttons, and various dispen...erse pipetting and diluting make this a lab favori... a manual pipette without any adverse effects on t...
...vus is so user-friendly that you'll learn how to u...stantly familiar menu and simple button layout, yo...quickly and easily. The large, clear display is ea...ns. The easily accessible two level menu offers t...
Medicine Products: